HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Low-Dose Ponatinib in Intolerant Chronic Myeloid Leukemia Patients: A Safe and Effective Option.

AuthorsAlessandra Iurlo, Daniele Cattaneo, Nicola Orofino, Cristina Bucelli, Matteo Molica, Massimo Breccia
JournalClinical drug investigation (Clin Drug Investig) Vol. 38 Issue 5 Pg. 475-476 (05 2018) ISSN: 1179-1918 [Electronic] New Zealand
PMID29363026 (Publication Type: Letter)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: